ACCURAY INC (ARAY) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ARAY • US0043971052

0.62 USD
+0.02 (+3.32%)
At close: Feb 6, 2026
0.61 USD
-0.01 (-1.61%)
After Hours: 2/6/2026, 8:18:06 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

ARAY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. ARAY has a bad profitability rating. Also its financial health evaluation is rather negative. ARAY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year ARAY has reported negative net income.
  • ARAY had a positive operating cash flow in the past year.
  • ARAY had negative earnings in each of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ARAY reported negative operating cash flow in multiple years.
ARAY Yearly Net Income VS EBIT VS OCF VS FCFARAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M

1.2 Ratios

  • ARAY has a Return On Assets of -4.23%. This is in the better half of the industry: ARAY outperforms 69.35% of its industry peers.
  • ARAY has a Return On Equity (-31.22%) which is in line with its industry peers.
  • Looking at the Return On Invested Capital, with a value of 0.44%, ARAY is in the better half of the industry, outperforming 65.59% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ARAY is significantly below the industry average of 8.80%.
Industry RankSector Rank
ROA -4.23%
ROE -31.22%
ROIC 0.44%
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)1.27%
ROIC(5y)2.46%
ARAY Yearly ROA, ROE, ROICARAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40 -60

1.3 Margins

  • ARAY has a Operating Margin of 0.33%. This is in the better half of the industry: ARAY outperforms 65.59% of its industry peers.
  • In the last couple of years the Operating Margin of ARAY has declined.
  • With a Gross Margin value of 30.93%, ARAY is not doing good in the industry: 75.27% of the companies in the same industry are doing better.
  • ARAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.33%
PM (TTM) N/A
GM 30.93%
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
ARAY Yearly Profit, Operating, Gross MarginsARAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARAY is destroying value.
  • Compared to 1 year ago, ARAY has more shares outstanding
  • ARAY has more shares outstanding than it did 5 years ago.
  • ARAY has a better debt/assets ratio than last year.
ARAY Yearly Shares OutstandingARAY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ARAY Yearly Total Debt VS Total AssetsARAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • ARAY has an Altman-Z score of -0.27. This is a bad value and indicates that ARAY is not financially healthy and even has some risk of bankruptcy.
  • ARAY has a Altman-Z score (-0.27) which is comparable to the rest of the industry.
  • ARAY has a debt to FCF ratio of 8.11. This is a slightly negative value and a sign of low solvency as ARAY would need 8.11 years to pay back of all of its debts.
  • ARAY's Debt to FCF ratio of 8.11 is fine compared to the rest of the industry. ARAY outperforms 73.66% of its industry peers.
  • ARAY has a Debt/Equity ratio of 2.06. This is a high value indicating a heavy dependency on external financing.
  • ARAY has a Debt to Equity ratio of 2.06. This is amonst the worse of the industry: ARAY underperforms 81.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF 8.11
Altman-Z -0.27
ROIC/WACC0.05
WACC8.37%
ARAY Yearly LT Debt VS Equity VS FCFARAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • ARAY has a Current Ratio of 1.56. This is a normal value and indicates that ARAY is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.56, ARAY is doing worse than 71.51% of the companies in the same industry.
  • ARAY has a Quick Ratio of 1.56. This is a bad value and indicates that ARAY is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.76, ARAY is doing worse than 83.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 0.76
ARAY Yearly Current Assets VS Current LiabilitesARAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • ARAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -418.00%.
  • ARAY shows a small growth in Revenue. In the last year, the Revenue has grown by 2.68%.
  • The Revenue has been growing slightly by 3.67% on average over the past years.
EPS 1Y (TTM)-418%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
Revenue 1Y (TTM)2.68%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-11.99%

3.2 Future

  • ARAY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 64.63% yearly.
  • ARAY is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.47% yearly.
EPS Next Y-779.31%
EPS Next 2Y-2.72%
EPS Next 3Y64.63%
EPS Next 5YN/A
Revenue Next Year2.63%
Revenue Next 2Y3.35%
Revenue Next 3Y3.47%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ARAY Yearly Revenue VS EstimatesARAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
ARAY Yearly EPS VS EstimatesARAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.1 -0.2 -0.3 -0.4 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • ARAY reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year ARAY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARAY Price Earnings VS Forward Price EarningsARAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

  • 77.42% of the companies in the same industry are more expensive than ARAY, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ARAY is valued cheaply inside the industry as 99.46% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.07
EV/EBITDA 18.48
ARAY Per share dataARAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • ARAY's earnings are expected to grow with 64.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.72%
EPS Next 3Y64.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ARAY!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ACCURAY INC

NASDAQ:ARAY (2/6/2026, 8:18:06 PM)

After market: 0.61 -0.01 (-1.61%)

0.62

+0.02 (+3.32%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04
Earnings (Next)04-28
Inst Owners69.89%
Inst Owner Change1.96%
Ins Owners3.69%
Ins Owner Change15.11%
Market Cap70.27M
Revenue(TTM)458.50M
Net Income(TTM)-19.32M
Analysts87.5
Price Target3.95 (537.1%)
Short Float %3.81%
Short Ratio4.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-111.58%
Min EPS beat(2)-128.76%
Max EPS beat(2)-94.4%
EPS beat(4)2
Avg EPS beat(4)8.92%
Min EPS beat(4)-128.76%
Max EPS beat(4)178.43%
EPS beat(8)4
Avg EPS beat(8)-49.84%
EPS beat(12)7
Avg EPS beat(12)-45.1%
EPS beat(16)9
Avg EPS beat(16)-43.64%
Revenue beat(2)2
Avg Revenue beat(2)0.92%
Min Revenue beat(2)0.82%
Max Revenue beat(2)1.02%
Revenue beat(4)4
Avg Revenue beat(4)3.6%
Min Revenue beat(4)0.82%
Max Revenue beat(4)9.35%
Revenue beat(8)6
Avg Revenue beat(8)1.33%
Revenue beat(12)9
Avg Revenue beat(12)1.73%
Revenue beat(16)11
Avg Revenue beat(16)1.57%
PT rev (1m)0%
PT rev (3m)-18.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1000%
EPS NY rev (1m)0%
EPS NY rev (3m)-614.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-17.94%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.78%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.16
P/FCF 4.07
P/OCF 3.15
P/B 1.14
P/tB N/A
EV/EBITDA 18.48
EPS(TTM)-0.26
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)0.15
FCFY24.59%
OCF(TTM)0.2
OCFY31.78%
SpS3.98
BVpS0.55
TBVpS-0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.23%
ROE -31.22%
ROCE 0.56%
ROIC 0.44%
ROICexc 0.59%
ROICexgc 0.94%
OM 0.33%
PM (TTM) N/A
GM 30.93%
FCFM 3.83%
ROA(3y)-1.87%
ROA(5y)-1.61%
ROE(3y)-17.92%
ROE(5y)-14.58%
ROIC(3y)1.27%
ROIC(5y)2.46%
ROICexc(3y)1.67%
ROICexc(5y)3.78%
ROICexgc(3y)2.44%
ROICexgc(5y)5.66%
ROCE(3y)1.6%
ROCE(5y)3.12%
ROICexgc growth 3Y-8.27%
ROICexgc growth 5Y-9.44%
ROICexc growth 3Y-8.35%
ROICexc growth 5Y-10.56%
OM growth 3Y-3.19%
OM growth 5Y-12.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.86%
GM growth 5Y-3.89%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 2.06
Debt/FCF 8.11
Debt/EBITDA 16.25
Cap/Depr 79.47%
Cap/Sales 1.12%
Interest Coverage 250
Cash Conversion 284.98%
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 0.76
Altman-Z -0.27
F-Score4
WACC8.37%
ROIC/WACC0.05
Cap/Depr(3y)136.79%
Cap/Depr(5y)106.47%
Cap/Sales(3y)1.52%
Cap/Sales(5y)1.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-418%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-650%
EPS Next Y-779.31%
EPS Next 2Y-2.72%
EPS Next 3Y64.63%
EPS Next 5YN/A
Revenue 1Y (TTM)2.68%
Revenue growth 3Y2.17%
Revenue growth 5Y3.67%
Sales Q2Q%-11.99%
Revenue Next Year2.63%
Revenue Next 2Y3.35%
Revenue Next 3Y3.47%
Revenue Next 5YN/A
EBIT growth 1Y217.25%
EBIT growth 3Y-1.09%
EBIT growth 5Y-8.91%
EBIT Next Year176.96%
EBIT Next 3Y97.35%
EBIT Next 5YN/A
FCF growth 1Y408.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y223.68%
OCF growth 3YN/A
OCF growth 5YN/A

ACCURAY INC / ARAY FAQ

What is the fundamental rating for ARAY stock?

ChartMill assigns a fundamental rating of 2 / 10 to ARAY.


What is the valuation status for ARAY stock?

ChartMill assigns a valuation rating of 3 / 10 to ACCURAY INC (ARAY). This can be considered as Overvalued.


How profitable is ACCURAY INC (ARAY) stock?

ACCURAY INC (ARAY) has a profitability rating of 2 / 10.


Can you provide the financial health for ARAY stock?

The financial health rating of ACCURAY INC (ARAY) is 2 / 10.